[Clinical aspects of activation of self-defense of the body by non-specific stimulant therapy].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D001996:Bronchopneumonia; D002491:Central Nervous System Agents; D002648:Child; D003879:Dermatologic Agents; D006801:Humans; D007223:Infant; D010936:Plant Extracts; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002491:Central Nervous System Agents; D003879:Dermatologic Agents; D010936:Plant Extracts; D013424:Sulfanilamides; D013449:Sulfonamides; D014688:Venoms; D000077145:Sulfanilamide
ANTIBIOTICS/therapeutic use; BRONCHOPNEUMONIA/in infant and child; PLANTS/extracts; SULFONAMIDES/therapeutic use; VENOMS/therapeutic use
Klinischer Beitrag zur Aktivierung der körpereigenen Abwehr durch unspezifische Reizkörpertherapie.